The technological complexity and massive capital requirements of developing modern mass spectrometers, sequencers, and robotic liquid handlers have triggered the most aggressive period of corporate consolidation in the history of science. As agile biotech startups push the boundaries of optical sensors and AI algorithms, they are rapidly absorbed by massive corporate entities. The Analytical...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek